OnQuality Pharmaceuticals Funding: $35M Raised, Series A
OnQuality Pharmaceuticals has raised $35M in total funding. Latest round: Series A. Backed by Shiyu Capital, Matrix Partners China, BioTrack Capital.
OnQuality Pharmaceuticals funding overview
OnQuality Pharmaceuticals has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for OnQuality Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Shiyu Capital, Matrix Partners China, BioTrack Capital, CASH Capital, Sinovation Ventures, FreeS Fund. 6 distinct backers are named across the disclosed rounds.
Frequently asked about OnQuality Pharmaceuticals funding
How much has OnQuality Pharmaceuticals raised?
OnQuality Pharmaceuticals has raised $35M in total disclosed funding across the rounds on record.
Who has invested in OnQuality Pharmaceuticals?
Shiyu Capital, Matrix Partners China, BioTrack Capital, CASH Capital, Sinovation Ventures, FreeS Fund are named among the investors backing OnQuality Pharmaceuticals.
What was the latest OnQuality Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in March 2021.
Where is OnQuality Pharmaceuticals based?
No headquarters location is disclosed for OnQuality Pharmaceuticals.
When did OnQuality Pharmaceuticals last raise?
The last disclosed OnQuality Pharmaceuticals round closed in March 2021 at Series A.
OnQuality Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.
Companies related to OnQuality Pharmaceuticals (32)
